Literature DB >> 7911126

Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model.

M Simons1, E R Edelman, R D Rosenberg.   

Abstract

We have used antisense phosphorothioate oligonucleotides to define the role played by proliferating cell nuclear antigen (PCNA) in neointimal accumulation of smooth muscle cells in a rat carotid artery injury model. The short-term extraluminal delivery of 250 nmol of antisense oligonucleotides, but not control oligonucleotides, immediately after arterial injury produces a 77% suppression of PCNA mRNA after 24 h and a 52% decrease in the frequency of medial smooth muscle cells expressing PCNA after 72 h. This reduction in PCNA expression is accompanied by a 59% decrease in the frequency of proliferating medial smooth muscle cells at 3 d as measured by BudR staining and an 80% decrease in neointimal accumulation assessed morphometrically at 2 wk. Thus, the expression of PCNA is required for medial smooth muscle cell growth in vivo and for neointimal formation after arterial injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911126      PMCID: PMC294440          DOI: 10.1172/JCI117240

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Upsloping ST segments. Easy to measure, hard to agree upon.

Authors:  L T Sheffield
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

2.  Effect of the myb gene product on expression of the PCNA gene in fibroblasts.

Authors:  S Travali; A Ferber; K Reiss; C Sell; J Koniecki; B Calabretta; R Baserga
Journal:  Oncogene       Date:  1991-06       Impact factor: 9.867

3.  Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF.

Authors:  G A Ferns; E W Raines; K H Sprugel; A S Motani; M A Reidy; R Ross
Journal:  Science       Date:  1991-09-06       Impact factor: 47.728

4.  A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro.

Authors:  A M Gewirtz; B Calabretta
Journal:  Science       Date:  1988-12-02       Impact factor: 47.728

5.  Kinetics of cellular proliferation after arterial injury. V. Role of acute distension in the induction of smooth muscle proliferation.

Authors:  A W Clowes; M M Clowes; J Fingerle; M A Reidy
Journal:  Lab Invest       Date:  1989-03       Impact factor: 5.662

6.  Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells.

Authors:  N K Banskota; R Taub; K Zellner; G L King
Journal:  Mol Endocrinol       Date:  1989-08

7.  Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin.

Authors:  C F Reilly
Journal:  J Cell Physiol       Date:  1990-02       Impact factor: 6.384

8.  Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor.

Authors:  V Lindner; M A Reidy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

9.  Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene.

Authors:  G Degols; J P Leonetti; N Mechti; B Lebleu
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

10.  Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients.

Authors:  M Nobuyoshi; T Kimura; H Ohishi; H Horiuchi; H Nosaka; N Hamasaki; H Yokoi; K Kim
Journal:  J Am Coll Cardiol       Date:  1991-02       Impact factor: 24.094

View more
  10 in total

Review 1.  DNA antisense strategies in the study of receptors for vasoactive peptides, and of growth and wound-healing factors.

Authors:  P D'Orléans-Juste; M G Sirois; E R Edelman; D Regoli; L H Pheng; G Bkaily; C J Lindsey
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

2.  Regulation of vascular smooth muscle cell growth: targeting the final common pathway.

Authors:  Angela M Taylor; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-01       Impact factor: 8.311

3.  Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries.

Authors:  R D Simari; H San; M Rekhter; T Ohno; D Gordon; G J Nabel; E G Nabel
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 4.  The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.

Authors:  Thierry Charron; Nafiseh Nili; Bradley H Strauss
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

5.  Butyrate inhibits proliferation-induced proliferating cell nuclear antigen expression (PCNA) in rat vascular smooth muscle cells.

Authors:  K Ranganna; F M Yatsu; B E Hayes; S G Milton; A Jayakumar
Journal:  Mol Cell Biochem       Date:  2000-02       Impact factor: 3.396

6.  Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.

Authors:  R E Law; W P Meehan; X P Xi; K Graf; D A Wuthrich; W Coats; D Faxon; W A Hsueh
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

7.  Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides.

Authors:  W Wang; H J Chen; A Schwartz; P J Cannon; C A Stein; L E Rabbani
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

8.  Developing peptide-based multivalent antagonists of proliferating cell nuclear antigen and a fluorescence-based PCNA binding assay.

Authors:  William P Bozza; Kun Yang; Jialiang Wang; Zhihao Zhuang
Journal:  Anal Biochem       Date:  2012-04-20       Impact factor: 3.365

9.  Phosphorothioate Oligodeoxynucleotide Inhibition of Restenosis.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-05       Impact factor: 2.300

10.  Gene expression profile of butyrate-inhibited vascular smooth muscle cell proliferation.

Authors:  Kasturi Ranganna; Zivar Yousefipour; Frank M Yatsu; Shirlette G Milton; Barbara E Hayes
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.